| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |